Brief Review of Systolic Blood Pressure Reduction and Cardiovascular Risk— Bundy 2017

This is a brief audio review.

In the article Systolic Blood Pressure Reduction and Risk of Cardiovascular Disease and Mortality: A Systematic Review and Network Meta-analysis published, 2017 by Bundy and Colleagues, The outcomes and key points are as noted: Linear associations between systolic blood pressure and risk of cardiovascular disease and all cause mortality were substantiated. Lowest risk systolic blood pressure group was the 120-124 mmhg. Due to high statistical power and large sample size this is hailed as the study that confirmed lower pressure is better in treatment of hypertension in patients at high risk for cardiovascular disease. In a Network meta-analysis, Systematic review with 144220 patients who were Patients from 42 trials analyzed via CiNeMa

This concludes the brief audio review of Systolic Blood Pressure Reduction and Risk of Cardiovascular Disease and Mortality: A Systematic Review and Network Meta-analysis, Bundy 2017.

Bundy JD, Li C, Stuchlik P, Bu X, Kelly TN, Mills KT, He H, Chen J, Whelton PK, He J. Systolic Blood Pressure Reduction and Risk of Cardiovascular Disease and Mortality: A Systematic Review and Network Meta-analysis. JAMA Cardiol. 2017 Jul 1;2(7):775-781. doi: 10.1001/jamacardio.2017.1421. PMID: 28564682; PMCID: PMC5710614.